Physician profile
Jay A Hertel
NPI 1629091897
$859.20
in general payments reported to CMS, 2019-2025
18 companies · $19.18 in 2025
The $19.18 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.23 · 2020: $159 · 2021: $356 · 2022: $275 · 2023: $14.73 · 2024: $16.63 · 2025: $19.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $209.71 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $102.55 | 2021-2024 | Farxiga |
| Lilly USA, LLC | $64.43 | 2020-2022 | |
| Novo Nordisk INC | $60.12 | 2021-2022 | |
| Abbott Laboratories | $58.64 | 2022 | |
| Eisai INC. | $51.50 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $46.77 | 2021 | |
| Amarin Pharma, INC. | $43.34 | 2021 | |
| Pfizer INC. | $42.71 | 2022 | |
| Janssen Pharmaceuticals, INC | $36.14 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.43 | 2022 | |
| Sanofi-Aventis U.S. LLC | $19.43 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.23 | 2019 | |
| Phadia US INC. | $19.18 | 2025 | Immunocap |
| Merck Sharp & Dohme LLC | $18.54 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $16.38 | 2022 | |
| Astellas Pharma US INC | $16.37 | 2021 | |
| Exact Sciences Corporation | $14.73 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Hertel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.